Insider · CIK 0001684531

Mulay James

Reports to the SEC for 2 companies · DALLAS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001684531

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-10	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+24.2K sh	$26.63	+$644K	24,165
2026-07-10	CGONCG Oncology, Inc.S Sale	Director	SSale	−24.2K sh	$75.16	−$1.82M	0
2026-07-10	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−24.2K sh	—	—	0
2026-06-15	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+654 sh	$3.72	+$2,432.88	654
2026-06-15	CGONCG Oncology, Inc.S Sale	Director	SSale	−654 sh	$60.12	−$39.3K	0
2026-06-15	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,310 sh	$12.59	+$16.5K	1,310
2026-06-15	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,310 sh	$60.12	−$78.8K	0
2026-06-15	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−654 sh	—	—	0
2026-06-15	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,310 sh	—	—	2,620
2026-06-04	CGONCG Oncology, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+9,354 sh	—	—	9,354
2026-04-17	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15.6K sh	$36.63	+$571K	15,600
2026-04-17	CGONCG Oncology, Inc.S Sale	Director	SSale	−15.6K sh	$73.01	−$1.14M	0
2026-04-17	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.6K sh	—	—	0
2026-03-16	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+654 sh	$3.72	+$2,432.88	654
2026-03-16	CGONCG Oncology, Inc.S Sale	Director	SSale	−654 sh	$63.50	−$41.5K	0
2026-03-16	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,310 sh	$12.59	+$16.5K	1,310
2026-03-16	CGONCG Oncology, Inc.S Sale	Director	SSale	−1,310 sh	$63.50	−$83.2K	0
2026-03-16	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−654 sh	—	—	654
2026-03-16	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,310 sh	—	—	3,930
2026-01-09	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+654 sh	$3.72	+$2,432.88	654
2026-01-09	CGONCG Oncology, Inc.S Sale	Director	SSale	−654 sh	$44.16	−$28.9K	0
2026-01-09	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.5K sh	$12.59	+$132K	10,491
2026-01-09	CGONCG Oncology, Inc.S Sale	Director	SSale	−10.5K sh	$52.99	−$556K	0
2026-01-09	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−654 sh	—	—	1,308
2026-01-09	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.5K sh	—	—	5,240
2025-10-09	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,903 sh	$3.72	+$22K	5,903
2025-10-09	CGONCG Oncology, Inc.S Sale	Director	SSale	−5,903 sh	$43.99	−$260K	0
2025-10-09	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,903 sh	—	—	1,962
2025-09-29	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.8K sh	$1.82	+$23.2K	12,755
2025-09-29	CGONCG Oncology, Inc.S Sale	Director	SSale	−12.8K sh	$39.19	−$500K	0
2025-09-29	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.8K sh	—	—	0
2025-09-19	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,574 sh	$1.82	+$6,504.68	3,574
2025-09-19	CGONCG Oncology, Inc.S Sale	Director	SSale	−3,574 sh	$38.99	−$139K	0
2025-09-19	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,574 sh	—	—	12,755
2025-09-18	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+19.1K sh	$1.82	+$34.8K	19,112
2025-09-18	CGONCG Oncology, Inc.S Sale	Director	SSale	−19.1K sh	$39.01	−$746K	0
2025-09-18	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−19.1K sh	—	—	16,329
2025-09-05	CGONCG Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+27K sh	$0.60	+$16.2K	27,015
2025-09-05	CGONCG Oncology, Inc.S Sale	Director	SSale	−12.3K sh	$30.47	−$376K	14,673
2025-09-05	CGONCG Oncology, Inc.S Sale	Director	SSale	−4,095 sh	$31.42	−$129K	10,578
2025-09-05	CGONCG Oncology, Inc.S Sale	Director	SSale	−7,465 sh	$32.64	−$244K	3,113
2025-09-05	CGONCG Oncology, Inc.S Sale	Director	SSale	−3,113 sh	$33.22	−$103K	0
2025-09-05	CGONCG Oncology, Inc. · Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−27K sh	—	—	0
2025-06-05	CGONCG Oncology, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+24.2K sh	—	—	24,165
2024-10-04	CGONCG Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.6K sh	—	—	15,600
2019-05-30	FLGTFulgent Genetics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2018-05-18	FLGTFulgent Genetics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2017-05-16	FLGTFulgent Genetics, Inc.A Award	Director	AAward	+2,000 sh	—	—	10,000
2016-10-26	FLGTFulgent Genetics, Inc.A Award	Director	AAward	+8,000 sh	—	—	8,000

Recent filings

Accepted (ET)
Jul 144
Mulay James0001193125-26-303188
SEC(opens sec.gov)
Jun 164
Mulay James0001684531-26-000002
SEC(opens sec.gov)
Jun 54
Mulay James0001193125-26-259691
SEC(opens sec.gov)
Apr 204
Mulay James0001193125-26-164013
SEC(opens sec.gov)
Mar 174
Mulay James0001193125-26-110831
SEC(opens sec.gov)
Jan 134
Mulay James0001193125-26-011756
SEC(opens sec.gov)

Companies

Address

C/O CG ONCOLOGY, INC. 3000 PEGASUS PARK DRIVE, SUITE 1640

DALLAS, TX, 75247